Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Roodman G.,,Biology of osteoclast activation in cancer,2001,Journal of Clinical Oncology,242,10.1200/JCO.2001.19.15.3562,United States,Article,San Antonio,0,Journal,2-s2.0-0035425227
Brown J.M.,,Osteoprotegerin and rank ligand expression in prostate cancer,2001,Urology,192,10.1016/S0090-4295(00)01122-5,United States;United States,Article,Seattle;Rockville,0,Journal,2-s2.0-0035319658
Zhang J.,,Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone,2001,Journal of Clinical Investigation,381,10.1172/JCI11685,United States,Article,Ann Arbor,1,Journal,2-s2.0-0035021176
Chirgwin J.M.,,Molecular mechanisms of tumor-bone interactions in osteolytic metastases,2000,Critical Reviews in Eukaryotic Gene Expression,171,10.1615/critreveukargeneexpr.v10.i2.50,United States;United States,Review,San Antonio;,0,Journal,2-s2.0-0033757999
Huang L.,,"Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-ÎºB in giant cell tumor of bone: Possible involvement in tumor cell-induced osteoclast-like cell formation",2000,American Journal of Pathology,194,10.1016/S0002-9440(10)64942-5,Australia,Article,Perth,0,Journal,2-s2.0-0033873632
Thomas R.,,Breast cancer cells interact with osteoblasts to support osteoclast formation,1999,Endocrinology,440,10.1210/endo.140.10.7037,Australia,Article,Fitzroy,1,Journal,2-s2.0-0033305222
Suda T.,,Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families,1999,Endocrine Reviews,1817,10.1210/edrv.20.3.0367,Japan,Review,Tokyo,1,Journal,2-s2.0-0033304730
Lacey D.L.,,Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation,1998,Cell,4250,10.1016/S0092-8674(00)81569-X,United States,Article,Thousand Oaks,1,Journal,2-s2.0-0032540319
Yasuda H.,,Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL,1998,Proceedings of the National Academy of Sciences of the United States of America,3287,10.1073/pnas.95.7.3597,Japan,Article,Shinjuku,1,Journal,2-s2.0-0032584208
